Stay updated with breaking news from Binding Site. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 First Quarter Conference Call. My name is Angela, and I'll be coordinating your call today.
TMO earnings call for the period ending March 31, 2024.
Transforming monoclonal gammopathy management to address an unmet clinical need through an innovative MS solution
Transforming monoclonal gammopathy management to address an unmet clinical need through an innovative MS solution
Small Molecule Innovator CDMO MarketThe Small Molecule Innovator CDMO Market is expected to be worth US$ 48.09 billion in 2023, rising to US$ 89.43 billion by 2033. During the forecast period, sales of small molecule innovator CDMO are expected to grow at a significant CAGR of 6.4%.The small molecule innovator contr...